The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Human monoamine oxidase is inhibited by tobacco smoke: β-carboline alkaloids act as potent and reversible inhibitors
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Some observations upon a new inhibitor of monoamine oxidase in brain tissue
Johnston, J. P. (1968) · Biochemical Pharmacology · doi:10.1016/0006-2952(68)90066-x · Cited by 1,578
MONOAMINE OXIDASE: From Genes to Behavior
Shih, J. C., Chen, K., & Ridd, M. J. (1999) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.22.1.197 · Cited by 1,206
Inhibition of monoamine oxidase B in the brains of smokers
Fowler, J. S., Volkow, N. D., Wang, G.-J., Pappas, N., Logan, J., MacGregor, R., Alexoff, D., Shea, C., Schlyer, D., Wolf, A. P., et al. (1996) · Nature · doi:10.1038/379733a0 · Cited by 656
Langston, J. W., Irwin, I., Langston, E. B., & Forno, L. S. (1984) · Neuroscience Letters · doi:10.1016/0304-3940(84)90293-3 · Cited by 435
Brain monoamine oxidase A inhibition in cigarette smokers
Fowler, J. S., Volkow, N. D., Wang, G.-J., Pappas, N., Logan, J., Shea, C., Alexoff, D., MacGregor, R. R., Schlyer, D. J., Zezulkova, I., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.14065 · Cited by 423
Smoking cessation and the course of major depression: A follow-up study
Glassman, A. H., Covey, L. S., Stetner, F., & Rivelli, S. (2001) · The Lancet · doi:10.1016/s0140-6736(00)05064-9 · Cited by 370
Clinical Pharmacology of MAO Inhibitors: Safety and Future
Yamada, M. (2004) · NeuroToxicology · doi:10.1016/s0161-813x(03)00097-4 · Cited by 324
Inhibition of Monoamine Oxidase A by β-Carboline Derivatives
Kim, H., Sablin, S. O., & Ramsay, R. R. (1997) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1996.9771 · Cited by 253
Monoamine oxidase and cigarette smoking
Fowler, J. S., Logan, J., Wang, G.-J., & Volkow, N. D. (2003) · NeuroToxicology · doi:10.1016/s0161-813x(02)00109-2 · Cited by 251
Smoking and Parkinson’s and Alzheimer’s disease: review of the epidemiological studies
Fratiglioni, L., & Wang, H.-X. (2000) · Behavioural Brain Research · doi:10.1016/s0166-4328(00)00206-0 · Cited by 245
Cited by
The therapeutic potential of monoamine oxidase inhibitors
Youdim, M. B. H., Edmondson, D., & Tipton, K. F. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1883 · Cited by 1,363
β-Carboline alkaloids in Peganum harmala and inhibition of human monoamine oxidase (MAO)
Herraiz, T., González, D., Ancín-Azpilicueta, C., Arán, V. J., & Guillén, H. (2010) · Food and Chemical Toxicology · doi:10.1016/j.fct.2009.12.019 · Cited by 357
Neuroinflammation in psychiatric disorders: PET imaging and promising new targets
Meyer, J. H., Cervenka, S., Kim, M.-J., Kreisl, W. C., Henter, I. D., & Innis, R. B. (2020) · The Lancet Psychiatry · doi:10.1016/s2215-0366(20)30255-8 · Cited by 270
Risk assessment of ritual use of oral dimethyltryptamine (DMT) and harmala alkaloids.
Gable, R. S. (2007) · Addiction · doi:10.1111/j.1360-0443.2006.01652.x · Cited by 244
Smoking and suicide: A brief overview
Hughes, J. R. (2008) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2008.06.003 · Cited by 236
Moura, D. J., Richter, M. F., Boeira, J. M., Pegas Henriques, J. A., & Saffi, J. (2007) · Mutagenesis · doi:10.1093/mutage/gem016 · Cited by 152
Comparison of the reinforcing properties of nicotine and cigarette smoke extract in rats
Costello, M. R., Reynaga, D. D., Mojica, C. Y., Zaveri, N. T., Belluzzi, J. D., & Leslie, F. M. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.31 · Cited by 78
Jensen, S. B., Olsen, A. K., Pedersen, K., & Cumming, P. (2006) · Synapse · doi:10.1002/syn.20258 · Cited by 27
Cross, S. J., Reynaga, D. D., Cano, M., Belluzzi, J. D., Zaveri, N. T., & Leslie, F. M. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.107846 · Cited by 14
Metadata
- Authors
- Herraiz, T., & Chaparro, C.
- Venue
- Biochemical and Biophysical Research Communications
- Publisher
- Elsevier BV
- Published
- 2005-01
- Volume
- 326
- Issue
- 2
- Pages
- 378-386
- ISSN
- 0006-291X (ISSN-L)
- OpenAlex
- W2060712684
- Cited by
- 258
- References
- 52
- FWCI
- 6.50
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.